While tumor response rate is a valuable metric, it has limitations:
It may not capture the long-term benefits of treatment, such as overall survival or quality of life. It might not reflect the heterogeneity of the tumor and its microenvironment. Response rates can be influenced by factors like the stage of cancer and prior treatments. Imaging techniques have limitations in detecting small or indeterminate lesions.
